Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0077-2027

HALYARD Laparoscopy Comprehensive Pack II REF: 49332 Recall

HALYARD Laparoscopy Comprehensive Pack II REF: 49332

FDA recall Class II

Ongoing

FDA lists this Class II recall for HALYARD Laparoscopy Comprehensive Pack II REF: 49332. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0077-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 26, 2026
FDA report date
Oct 14, 2026
Quantity in commerce
396 kits
Distribution
See key details
FDA cause
Labeling design

What is being recalled?

HALYARD Laparoscopy Comprehensive Pack II REF: 49332

Affected model & UDI checker

Search the exact identifiers published for Z-0077-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
49332HALYARD Laparoscopy Comprehensive Pack II REF: 49332Check source noticeNot specified
FDA code information

UDI-DI: 10680651493320 (unit level), 30680651493324 (case level) Lot Numbers: GL25271CXA-Expiry Date: 2029/3/30; GL25296CXA-Expiry Date: 2029/3/30; GL26076CXA-Expiry Date: 2029/5/31

View the original FDA recall notice

Why was this product recalled?

Laparoscopy packs labeled as "latex free" were found to contain a latex urethral catheter

What actions did GRI Medical & Electronic Technology Co., Ltd. take?

On August 26, 2026, GRI Medical & Electronics Technology Co., Ltd is a Urgent: Medical Device Recall Notification via Email to affected consignees. GRI ask consignees to take the following action: 1. Immediately segregate all affected product lots in a dedicated, clearly marked quarantine zone within your warehouse and all downstream hospital storage areas. Use prominent red labels stating RECALL DO NOT USE OR DISTRIBUTE to separate defective kits from compliant inventory. 2. Cease all outbound shipments, internal transfers and cross-facility redistribution of every lot of 49332 Laparoscopy Comprehensive Pack II. 3. Conduct a full physical inventory count of all recalled units on hand and document exact quantities per lot number for submission to GRI. 4. Share this notice with all staff who need awareness and any facility in which the affected product has been transferred to. 5. Within 3 business days customers are requested to complete and return the Recall Acknowledgment Form via the following official channels: Affairs team at [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology